logo
Plus   Neg
Share
Email

Valeant Posting Strong Gain On Sale Of INova Pharmaceuticals

Shares of Valeant Pharmaceuticals (VRX) have shown a strong move to the upside during trading on Thursday, with the drug maker jumping by 8.6 percent.

The advance by Valeant comes after the company announced the sale of its iNova Pharmaceuticals unit to funds managed by Pacific Equity Partners and The Carlyle Group for $930 million in cash.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
The Coca-Cola Company (KO) reported that its first-quarter comparable earnings per share from continuing operations grew 8% year-over-year to $0.47. On average, 20 analysts polled by Thomson Reuters expected the company to report profit per share of $0.46 for the quarter. Analysts' estimates typically exclude special items. Net income from continuing operations increased 12% to $1.33 billion. Earnings per share from continuing operations rose 13% to $0.31. Eli Lilly and Co. (LLY) Tuesday reported a profit for its first-quarter, compared to a loss last year, primarily driven by higher operating income. Quarterly revenue increased 9 percent, driven primarily by the increased demand for new pharmaceutical products. The company raised its 2018 outlook. Both adjusted earnings per share and revenue for the quarter beat analysts' expectations. Shares of SAP SE were gaining around 3 percent in German trading after the software giant reported Tuesday higher first-quarter profit with strong growth in cloud subscriptions and support revenues. The company further lifted its outlook for fiscal 2018. CEO said, "With an increasing share of predictable revenues, our beyond expectations profitability is cause for even greater shareholder confiden
Follow RTT